Literature DB >> 2890308

Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan.

R L Binder1, H Kazamatsuri, T Nishimura, D E McNiel.   

Abstract

The authors studied neuroleptic drug response in 126 inpatients in Japan. They found similar prevalences and risk factors of tardive dyskinesia and neuroleptic-induced parkinsonism in Japan and the West, despite cross-cultural differences in psychiatric practice.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2890308     DOI： 10.1176/ajp.144.11.1494

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  6 in total

1.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

Review 2.  Tardive dyskinesia in non-western countries: a review.

Authors:  A K Pandurangi; Y A Aderibigbe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 3.  Neuroleptic-induced dysphagia: case report and literature review.

Authors:  Rainer Dziewas; Tobias Warnecke; Martina Schnabel; Martin Ritter; Darius G Nabavi; Matthias Schilling; E Bernd Ringelstein; Thomas Reker
Journal:  Dysphagia       Date:  2006-10-06       Impact factor: 3.438

4.  A 15-year open study on a cohort of West-African out-patients with a chronic psychosis.

Authors:  Joop T V M de Jong; I H Komproe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-08       Impact factor: 4.328

5.  Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.

Authors:  H Matsuo; A Matsui; R Nasu; H Takanaga; N Inoue; F Hattori; H Ohtani; Y Sawada
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

Review 6.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.